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Background: Several low-molecular-weight phenolic acids are present in the blood of septic patients at high levels.
The microbial origin of the most of phenolic acids in the human body was shown previously, but
pathophysiological role of the phenolic acids is not clear. Sepsis is associated with the excessive production of
reactive oxygen species (ROS) in both the circulation and the affected organs. In this work the influence of phenolic
acids on ROS production in mitochondria and neutrophils was investigated.
Methods: ROS production in mitochondria and neutrophils was determined by MCLA- and luminol-dependent
chemiluminescence. The rate of oxygen consumption by mitochondria was determined polarographically. The
difference of electric potentials on the inner mitochondrial membrane was registered using a TPP+-selective
electrode. The formation of phenolic metabolites in monocultures by the members of the main groups of the
anaerobic human microflora and aerobic pathogenic bacteria was investigated by the method of gas
chromatography–mass spectrometry.
Results: All phenolic acids had impact on mitochondria and neutrophils, the main producers of ROS in tissues and
circulation. Phenolic acids (benzoic and cinnamic acids) producing the pro-oxidant effect on mitochondria inhibited
ROS formation in neutrophils. Their effect on mitochondria was abolished by dithiothreitol (DTT). Phenyllactate and
p-hydroxyphenyllactate decreased ROS production in both mitochondria and neutrophils. Bifidobacteria and
lactobacilli produced in vitro considerable amounts of phenyllactic and p-hydroxyphenyllactic acids, Clostridia s.
produced great quantities of phenylpropionic and p-hydroxyphenylpropionic acids, p-hydroxyphenylacetic acid was
produced by Pseudomonas aeruginosa and Acinetobacter baumanii; and benzoic acid, by Serratia marcescens.
Conclusions: The most potent activators of ROS production in mitochondria are phenolic acids whose effect is
mediated via the interaction with thiol groups. Among these are benzoic and cinnamic acids. Some phenolic acids,
in particular phenyllactate and p-hydroxyphenyllactate, which decrease ROS production in mitochondria and
neutrophils, can play a role of natural antioxidants. The results indicate that low-molecular weight phenolic acids of
microbial origin participate in the regulation of the ROS production in both the circulation and tissues, thereby
affecting the level of oxidative stress in sepsis.
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The systemic inflammatory response syndrome (SIRS) is
the most frequent complication in critical states, which
develop as a result of severe diseases, traumata, and sepsis.
The development of SIRS is a complex process, which is
accompanied by hematological, hemodynamic, and meta-
bolic disorders [1-3]. Two stages of SIRS are recognized:
the initial proinflammatory stage, which involves the acti-
vation of neutrophils, tissue macrophages, an increase in
the production of cytokines and reactive oxygen species
(ROS), and the later stage, which is characterized by a
decrease in the level of cytokines and neutrophils, the
appearance of the signs of multiple organ failure and per-
sistent tissue hypoxia [4]. The mechanisms of the develop-
ment of multiple organ failure remain still obscure. The
prevalent hypothesis regarding the mechanisms of sepsis
and septic shock indicates that this syndrome is caused by
an excessive defensive and inflammatory responses char-
acterized by an increased generation of ROS, nitric oxide
(NO), and inflammatory cytokines [4,5]. It was assumed
that the level of oxidative stress is crucial in the genesis
and outcome of sepsis [6]. Sepsis is associated with the
excessive ROS production in both the circulation and the
affected organs. In pathological complications, such
as acute lung injury and sepsis, excess ROS production
by neutrophils may influence vicinal cells of endothelium
or epithelium, contributing to the inflammatory tissue
injury [7,8].
Along with neutrophils, mitochondria, as the main pro-
ducers of ROS in tissues, play a very important role in this
process. Studies of samples from various organs of septic
patients and experimental evidence obtained on animals
with induced sepsis showed that, as the severity of disease
increases, the oxygen consumption in tissues falls [9,10].
Recent data indicate that these processes are related to the
disturbances of mitochondrial functions [11-13]. The
causes of mitochondrial dysfunction in the systemic in-
flammatory response syndrome remain unknown.
Microbial metabolites are actively involved in maintain-
ing the homeostasis of a healthy human body and contrib-
ute, positively or negatively, to the development of
pathological processes. It was found that the level of some
microbial metabolites, in particularly phenolic acids, was
substantially changed in the blood sera from patients with
sepsis [14,15]. In critical states, such as pneumonia asso-
ciated with artificial lung ventilation and sepsis, a multiple
increase in the level of p-hydroxyphenylacetic, phenyllac-
tic, and p-hydroxyphenyllactic acids occur, whereas the
amount of phenylacetic and phenylpropionic acids
decreases compared with the norm. There is evidence that
low molecular weight microbial metabolites of phenolic
nature affect the individual enzymes, receptors, and ROS
production [16-18]. The pathophysiological role of phen-
olic acids in the development of sepsis is not clear. In thiswork, we studied the role of low-molecular-weight phen-
olic acids of microbial origin in the dysfunction of mito-
chondria and neutrophils. It was found that phenolic acids
exerting pro-oxidant effects on mitochondria inhibited
ROS formation by neutrophils. The species-specific pro-
duction of these metabolites by the anaerobic human
microflora and aerobic pathogenic bacteria was deter-
mined. The results obtained permit us to consider phen-




The ability of bacteria to produce phenolic acids in vitro
was studied on isolated microbial strains, which were
divided into two groups depending on cultivation
conditions:
(1) Anaerobic bacteria (species Bifidobacteria,
Lactobacteria, Bacteroides, Eubacteria, and
Clostridia) as representatives of the microbiota of a
healthy human. Cultivation was carried out under
anaerobic conditions on Schaedler medium [19];
(2) Facultatively aerobic bacteria (species
Staphylococcus, Enterococcus, Escherichia, and
Klebsiella) and aerobic bacteria (non fermenting
gram-negative species Pseudomonas and
Acinetobacter), whose portion in ill patients
increases with the alteration of the gut flora. These
bacteria are known as the main causing agents of
purulent complications, bacteremia, and sepsis.
Cultivation was carried out under aerobic
conditions in tryptone soya broth (HIMEDIA) [14].
Gas chromato-mass spectrometry (GC-MS) analysis
Samples of bacterial cultures were centrifuged for
15 min at 800 g, and an internal standard for GC-MS
analysis (10 μl of ethanol solution containing 400 ng D5-
benzoic acid) was introduced into the supernatant
(1 ml). Then, each sample was treated with diethyl ether
(2 x 1 ml) at pH 2, and the ether extract was evaporated
to dryness at 40оC. For obtaining trimethylsilyl (TMS)
derivatives of the phenolic acids, the residue was treated
with 20 μl of N,O-bis(trimethylsilyl)trifluoroacetamide
(BSTFA) (Fluka) at 80°C for 15 min. The resulting sam-
ple was dissolved in hexane (80 μl) and analyzed by the
GC-MS method. Control samples were subjected to
analogous treatment. Compounds in samples of micro-
bial cultures were analyzed using an Agilent 6890/5973
gas chromato-mass spectrometer (Agilent Technologies,
USA) in the full scan mode [19]. The components were
separated by chromatography on a HP5MS quartz capil-
lary column. Mass spectrometry data for the identifica-
tion of the compounds were obtained using the database
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ples was determined in triplicates. The results were
recalculated in μg/ml and were well reproducible. The
statistical significance of difference was estimated by the
Student’s t-tests. The data shown represent the means ±
standard error of means (S.E.M.).
Isolation of mitochondria
The liver and blood samples were taken from male Wistar
rats (200–250 g) after decapitation. This study respected
the European Union regulations for animal experiments.
Mitochondria were isolated from the liver of Wistar rats
by the standard procedure of differential centrifugation in
medium containing 300 mM sucrose, 1 mM EGTA, and
10 mM Tris–HCl buffer (pH 7.4) [18]. A mitochondrial
pellet was washed twice with the isolation medium con-
taining no EGTA, resuspended in the medium of the same
composition, and stored on ice. The protein content was
determined by the Lowry method.
Isolation of neutrophils
Peripheral blood from rat was collected into tubes with
anticoagulant (11 mg heparin in 4 ml phosphate buf-
fered saline (PBS) containing 136.9 mM NaCl, 2.7 mM
KCl, 1.9 mM NaH2PO4) and neutrophils were isolated
by a combination of hypotonic treatment and Ficoll-
urografin gradient centrifugation [20,21]. For hypotonic
hemolysis heparinized blood was mixed with cold dis-
tilled water in a ratio of 1:2 for 20 s and after the restor-
ation of tonicity by twice PBS solution was centrifuged
for 5 min at 180x g at 4oC. The pellet was washed with
PBS and 2 ml of leukocyte suspension was layered on
the gradient of Ficoll- urografin 1,077/1,119 (3 ml) and
centrifuged for 15 min at 180x g at 4oC. A fraction of
cells obtained was twofold washed with PBS and resus-
pended in Hanks solution (pH 7.2). The content of neu-
trophils in the fraction was no less than 96%.
Mitochondrial membrane potential and oxygen
consumption assay
The rate of oxygen consumption by mitochondria was
determined polarographically using an electrode of a
closed oxygen meter of the Clark type. The difference of
electric potentials on the inner mitochondrial membrane
was determined from the distribution of the lipophilic
cation of tetraphenylphosphonium (TPP+) whose con-
centration in external medium [TPP+]out was registered
using a TPP+-selective electrode [22]. The parameters
were simultaneously registered using a multichannel
computerized device Record-4 (Russia). The incubation
medium contained 120 mM KCl, 2 mM KH2PO4, 4 mM
pyruvate, 4 mM malate, and 10 mM HEPES (pH 7.4).
Other experimental conditions are given in figure cap-
tions. The data of typical experiments performed no lessthan in triplicates with different mitochondrial prepara-
tions are presented.
ROS production
The production of ROS in mitochondria was determined
by measuring the chemiluminescence of the Cypridina
luciferin analog 2-methyl-6-(p-methoxyphenyl)-3,7-dihy-
droimidazo[1,2-a]pyrazine-3-one (MCLA) [23]. MCLA-
dependent chemiluminescence was recorded by a СL-100
chemiluminometer (Russia) simultaneously in several
cuvettes with samples (250 μl) containing 0.5 mg of mito-
chondrial protein, 4 mM substrate of oxidation, and
40 μM MCLA. The generation of superoxide anion was
induced by 25 μM menadione [24]. The production of
ROS by phagocytes was examined by the method of
luminol-dependent chemiluminescence (LCL) [20,21].
Measurements were carried out on a Tecan Infinite F200
microplate reader (Austia) in 96-well plates (Greiner
CELLSTAR). The effect of compounds being tested was
assessed as follows. Neutrophils (150000 cells per sample)
were incubated for 5 min at 37oC in Hanks medium
containing luminol (100 μM) to which a corresponding
compound was added (100 and 200 μM). Then, a phorbol
12-myristate 13-acetate (PMA) 0.28 μM solution was
added to the suspension of neutrophils, and LCL was
recorded. The changes in LCL intensity by the action of
the compounds were estimated relative to the control
LCL values: ILCL = I PA+PMA/I solvent+PMA) x 100%, where
ILCL is the recorded value of LCL, I PA+PMA is the intensity
of LCL of a suspension of neutrophils in the presence of
substances being examined and PMA, Isolvent+PMA is the
intensity of LCL of a suspension of neutrophils in the
presence of alcohol (in a volume equivalent to that of
phenolic acids) and PMA. The value of LCL of a suspen-
sion of neutrophils in the presence of alcohol served as a
background value. Statistical processing of the data was
carried out using the program MS Excel 2003. The differ-
ences were considered significant at P ≤ 0.05.
Results
The effect of phenolic acids on the menadione-activated
ROS production in mitochondria was determined by
measuring the chemiluminescence of MCLA (cypridina
luciferin analog 2-methyl-6-(p-methoxyphenyl)-3,7-dihy-
droimidazo[1,2-a]pyrazine-3-one). As seen in Figure 1A
menadione induced generation of superoxide anion in
rat liver mitochondria (control). In the presence of cin-
namate, benzoate, and 3-phenylpropionate, the rate of
ROS production was substantially higher than in the
presence of menadione alone (traces 1–3). A similar
effect was observed in the presence of phenylacetate
(trace 4), whereas phenyllactate, p-hydroxyphenylacetate,
and р-hydroxyphenyllactate decreased ROS production
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Figure 1 Effect of phenolic acids on ROS production in
mitochondria. A- Effect of phenolic acids on chemiluminescence of
MCLA in mitochondria in the presence of redox-cycler menadione
(MQ): 1, cinnamic; 2- benzoic, 3- phenylpropionic, 4- phenylacetic, 5-
control, 6- p-hydroxyphenylpropionic, 7- phenyllactic; the
concentrations of phenolic acids 100 μM, menadione 25 μM, MCLA
40 μM, pyruvate 4 mM, and rotenone 2.5 μM. B- Comparison of the
effect of phenolic acids: cinnamic (CA), benzoic (BA),
phenylpropionic (PPA), phenylacetic (PAA), p-
hydroxyphenylpropionic (p-HPPA), phenyllactic (PLA), p-
hydroxyphenyllactic (p-HPLA) at a concentration of 100 μM on
menadione-activated ROS production. Data are expressed as the































































Figure 2 Effect of phenolic acids of microbial origin on NAD-
dependent respiration of mitochondria. The inhibition of NAD-
dependent respiration of mitochondria by cinnamic acid was taken
to be 100%. The concentration of phenolic acids was 100 μM. Data
are expressed as the means ± SEM of five independent
determinations.
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of 100 μM on the menadione-activated ROS production.
Similar data were obtained in the study of the effect of
the phenolic acids on respiration of mitochondria oxidiz-
ing pyruvate, substrate of complex I of respiratory chain.
It was found that phenolic acids, which increased of the
menadione-activated ROS production, inhibited mito-
chondrial respiration, whereas with phenyllactate, p-
hydroxyphenylacetate, and р-hydroxyphenyllactate
statistically differences were not observed (Figure 2).
Moreover the increase of concentration of cinnamate,
benzoate, and phenylacetate (> 100 μM) led to a de-
crease in the mitochondrial membrane potential upon
pyruvate oxidation. The addition of succinate restored
the potential to the control level (Figure 3A). Dithiotrei-
tol (DTT) also restored the potential to the control level(Figure 3B). The SH-reagent N-ethylmaleimide (NEM)
at concentrations above 250 μM acted similarly, and its
effect on the mitochondrial membrane potential was
prevented by the preliminary addition of DTT (data not
shown).
All phenolic acids decreased ROS production in PMA-
activated neutrophils (Figure 4 A). DTT did not eliminate
the effect of cinnamic and benzoic acids on neutrophils, as
distinct from mitochondria. Compared with cinnamic and
benzoic acids, which acted at concentrations of 100–
200 μM, NEM was more effective in inhibiting the ROS
production. It produced the inhibitory effect even at a con-
centration as low as 5 μM and an almost 100% inhibition at
a concentration of 25 μM. All other phenolic acids
decreased ROS production at different degree (Figure 4 B).
To identify the species-specific production of these
phenolic acids by microorganisms, we studied the for-
mation of phenolic metabolites in monocultures by the
members of the main groups of the anaerobic human
microflora and aerobic pathogenic bacteria by the
method of gas chromatography–mass spectrometry.
Figure 5 shows the level of phenolic acids produced by
anaerobic human microflora (A, B) and aerobic patho-
genic bacteria (C). It was found that bifidobacteria and
lactobacilli produce in vitro considerable amounts
of phenyllactic (64.9 and 35.4 μg/ml, respectively) and
p-hydroxyphenyllactic acids (39.4 and 13.7 μg/ml, re-
spectively). Clostridia sporogenes, as distinct from C. per-
fringens, produced great quantities of phenylpropionic
(155.7 μg/ml) and p-hydroxyphenylpropionic acids
(123.2 μg/ml). Bacteroids produced only phenylacetic
acid, and Eubacterium lentum formed phenyllactic acid






















































Figure 3 Effect of cinnamic and benzoic acids on mitochondrial membrane potential. A- Effect of cinnamic acid (CA) on ΔΨm upon the
oxidation of pyruvate and its elimination by succinate; B – Removal of the effects of cinnamic (CA) and benzoic (BA) acids by DTT. The
concentrations of phenolic acids were 200 μM, DTT 2 mM, pyruvate 4 mM, and succinate 4 mM.
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hydroxyphenyllactic acids is hundreds of times lower
(Figure 5C). Phenyllactic (0.25–3.5 μg/ml) and p-
hydroxyphenyllactic (0.45–1.3 μg/ml) acids were pro-
duced by Escherichia coli, Klebsiella pneumonia,




















































Figure 4 Effect of phenolic acids of microbial origin and thiol reagen
luminol in PMA-activated neutrophils, 1- control, 2- benzoic acid, 3- cinnam
thiols reagents (DTT, 1 mM and NEM, 5 and 25 μМ) on ROS production infermenting gram-negative Pseudomonas aeruginosa and
Acinetobacter baumanii, which normally are absent in
the microbiota of the human intestine, did not produce
phenyllactic and p-hydroxyphenyllactic acids at all. How-
ever, they specifically produce p-hydroxyphenylpropionic
acid, which is absent in the overwhelming majority ofe (sec)
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Figure 5 Species-specific production of phenolic acids by anaerobic human microbiota and pathogenic facultative aerobes.
A- abundant phenolic acids (ng/ml) produced by anaerobic human microbiota; B – minor phenolic acids (ng/ml) produced by the same
microbiota; C - phenolic acids (ng/ml) produced by pathogenic facultative aerobes.
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http://www.jbiomedsci.com/content/19/1/89bacteria examined. p-hydroxybenzoic acid was produced
by Pseudomonas aeruginosa, and benzoic acid, by Serra-
tia marcescens. Cinnamic acid was not detected as ametabolite of these microorganisms when cultivated in
monocultures. Thus, these results reveal species-specific
production of individual phenolic acids by bacteria.
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The results of the study indicate that low-molecular
weight phenolic acids of microbial origin can be involved
in the regulation of inflammatory syndrome. All phen-
olic acids had impact on mitochondria and neutrophils,
the main producers of ROS in tissues and circulation. It
was found that the most effective activators of ROS pro-
duction in mitochondria are those phenolic acids whose
effect is mediated via the interaction with thiol groups.
Among these are cinnamic and benzoic acids, the effects
of which, similar to the effect of NEM, was abolished by
DTT. As it follows from our data, this effect is related
to the inhibition of complex I of the respiratory chain.
Other phenolic acids, such as phenyllactate and p-
hydroxyphenyllactate, decreased the ROS production in
mitochondria, exhibiting the antioxidant effect.
All phenolic acids decreased the ROS production in
neutrophils. This finding agrees well with the earlier
reported inhibition of chemiluminescence in human
neutrophils in the presence of 3,4-dihydroxyphenylacetic,
3-hydroxyphenylacetic, and other monocyclic phenolic
acids generated by the human intestinal microflora
[25-28]. The inhibition was related to the scavenging of
the superoxide anion. This mechanism may also under-
lie the action of phenyllactic and p-hydroxyphenyllactic
acids on mitochondria and neutrophils. On the con-
trary, cinnamic and benzoic acids do not act as ROS
scavengers but exhibit the prooxidant activity, interact-
ing with thiol groups. Presumably, their effect can be
explained by the inhibition of NADPH-oxidase. It has
been shown earlier that redox processes, among them
thiol-dependent, are involved in the mechanism of ac-
tion of NADPH oxidase inhibitors [28].
Some phenolic acids, in particular phenyllactate and
hydroxyphenyllactate, which decrease ROS production in
both mitochondria and neutrophils, can have the protect-
ing effect on organs and tissues. They can play a role of
natural antioxidants. Recent trends are towards the use of
mitochondrial therapy aimed at providing cells and tissues
with particular antioxidants. Indeed, in some cases, the
application of antioxidants in induced sepsis led to the
improvement of oxidative phosphorylation and a partial
restoration of hemodynamic parameters and functions of
the organism [29,30]. Based on these data, it can be
assumed that, when affecting targets in the organism, mi-
crobial metabolites can enhance or reduce the inflamma-
tory syndrome. If this is so, the physiological significance
of these effects of phenolic acids can be different depend-
ing on the stage of the inflammatory syndrome since the
response to a septic insult is a dynamic process character-
ized by distinct differences between the acute and chronic
phases of the illness. By inhibiting ROS production in neu-
trophils, they decrease the immune response of the organ-
ism, which can produce a beneficial effect at late stages ofsepsis associated with bioenergetic failure and an adverse
effect at the early stage of pro-inflammation.
All of these metabolites have been identified in the in-
testine and blood. The total concentration of phenolic
acids in the human intestine exceeds 400 μM [31], in
blood it varies from 5.3 μM in the norm to 55 μM in sep-
sis [15,18]. There is evidence indicating a strong increase
in the level of phenylacetate to 3.49 mmol/l in the blood
plasma of patients with end-stage renal disease [16]. In the
present study we obtained data on the species-specific
production of those metabolites that affect the functions
of mitochondria and neutrophils. Below primary emphasis
in the analysis will be placed on those phenol acids that
show the capacity to suppress ROS production by both
mitochondria and neutrophils. These are phenyllactic and
p- hydroxyphenyllactic acids. The results showed that all
anaerobes studied (except Bacteroides fragilis) are capable
of producing these acids, and the greatest quantities
(39–111 μg/ml of phenyllactic acid and 26–35 μg/ml of p-
hydroxyphenyllactic acid) are produced by Eubacterium
lentum, Bifidobacterium bifidum, and Lactobacterium fer-
mentum. It is known that just these gram-positive anaer-
obic bacteria form a dominant pool of the intestinal
microbiota of a healthy human. This fact may point to the
biological expediency of the capacity of these bacteria for
phenyllactic and p- hydroxyphenyllactic acids production
as a mechanism of host–bacteria interaction that prevents
the development of inflammation in response to the con-
tinuous contact of these bacteria with the intestinal mu-
cosa. In septic patients, this physiological role of
anaerobes is lost since the vital activity of bifido-, lato-,
and eubacteria in the ill organism is suppressed, so that
they are almost entirely eliminated from the intestine. In
aerobic bacteria, phenyllactic and p- hydroxyphenyllactic
acids were produced only by those bacteria that are con-
stantly present in the biocenosis of the human (Escheri-
chia coli, Klebsiella pneumonia, Staphylococcus spp,
Enterococcus faecalis). Non-fermenting gram-negative
Pseudomonas aeruginosa and Acinetobacter baumanii,
which normally are absent in the microbiota of the human
intestine, did not produce phenyllactic and p- hydroxyphe-
nyllactic acids at all. However, these microorganisms spe-
cifically produce p-hydroxyphenylacetic acid, which is
absent in the overwhelming majority of bacteria examined.
In our experiments, p-hydroxyphenylacetic acid showed
the capacity to inhibit the ROS production in neutrophils.
During the development of bacteremias and purulent foci
of infection associated with Pseudomonas aeruginosa and
Acinetobacter baumanii, their metabolite p-hydroxyphe-
nylacetic acid can directly enter the systemic blood flow
and inhibit the phagocytic activity of neutrophils.
The production of other metabolites is more species-
specific. Among metabolites increasing the ROS produc-
tion in mitochondria, the production of phenylacetic acid
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acid, in Clostridium sporogenes. Benzoic acid was found in
minor amounts in Serratia marcescens. Cinnamic acid was
absent in isolated bacterial strains; however, the fact of its
microbial origin was documented in other studies where
benzoic and cinnamic acids were detected in plasma and
fecal water from human volunteers [31]. Cinnamic acid is
a product of phenylalanine ammonia-lyase, a ubiquitous
higher-plant enzyme that catalyzes the nonoxidative de-
amination of phenylalanine to cinnamic acid. This enzyme
was encountered only in a few bacteria, where it is
involved in benzoyl-CoA biosynthesis, namely in “Strepto-
myces maritimus” and Sorangium cellulosum, as well as in
the biosynthesis of cinnamamide in Streptomyces verticil-
latus [32-34].
It is known that the inflammatory response is character-
ized by a massive increase in the production of reactive
oxygen species, nitric oxide, and inflammatory cytokines.
These pathologic factors have a great impact on
mitochondrial functions in sepsis [5]. As distinct from
pathogen-associated molecular patterns such as bacterial
lipopolysaccharides and lipoteichoic acids, which are
recognized by immune cells and initiate an acute response
to pathogens [4], microbial phenolic acids may be assumed
to regulate the magnitude of this response. A source of
phenolic acids in the organism is the anaerobic degrad-
ation of aromatic amino acids and polyphenols by micro-
flora. Consequently, nutritional or medicinal plant foods
may influence the concentration of gut microbial-derived
low-molecular phenolic acids. In humans, the antioxidants
such as 4-hydroxyphenylacetic, 4-hydroxyphenylpropionic,
and 3,4-dihydroxyphenylacetic acids were identified as the
metabolites of quercetin, catechin, and other polyphenols
[35,36]. As follows from our data, phenolic acids act on tar-
gets that produce ROS in the organism. Some phenolic
acids, which decrease ROS production in both mitochon-
dria and neutrophils, can play a role of natural antioxi-
dants. By affecting neutrophils, they retard the immune
response, whereas while acting on mitochondria, they pre-
vent the development of multiple organ failure or reduce it.
Conclusions
According to the data of clinical examination, the high
levels of phenyllactic and p- hydroxyphenyllactate acids in
blood correlate with the development of sepsis and the risk
of lethal outcome. There is evidence for the microbial origin
of these phenolic acids in human blood. The suppression of
ROS production by phenyllactic, p- hydroxyphenyllactic
acids, and p-hydroxyphenylacetic acid in mitochondria and
neutrophils can substantially contribute to the course of
local infections and sepsis. The results obtained are particu-
larly urgent in view of the fact of their production by
Klebsiella pneumonia, Escherichia coli, Pseudomonas
aeruginosa, and Acinetobacter baumanii, which are themost frequent causing agents of hospital infectious compli-
cations and sepsis.
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